SUSMED, Inc. (4263) Other
Market cap
¥16.6B
P/E ratio
Susmed develops digital therapeutic apps and IT platforms that help pharmaceutical companies and healthcare providers conduct clinical trials and analyze medical data more efficiently.
| 2017/06 | 2018/06 | 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Return on Assets | - | - | - | - | -27 | -2.6 | -1 | -2.8 | -3.2 |
| Return on equity (%) | - | - | - | ||||||
| Employees | 1 | 5 | 10 | 13 | 22 | 24 | 33 | 39 | 43 |